The demonstration of glomus tumours by subtraction MRI

G A Lloyd1, A D Cheesman, P D Phelps

  • 1Royal National Throat Nose and Ear Hospital, London, UK.

Neuroradiology
|January 1, 1992
PubMed

Insights

Subtraction gadolinium-enhanced MRI effectively visualizes glomus tumors, aiding surgical planning and post-operative monitoring. This technique optimizes imaging by removing signals from fat and normal tissues, highlighting tumor vascularity.

Area of Science:

  • Radiology
  • Oncology
  • Neurosurgery

Background:

  • Glomus tumors, particularly skull base lesions, present diagnostic challenges.
  • Accurate tumor delineation is crucial for surgical approach determination and treatment monitoring.

Purpose of the Study:

  • To evaluate the efficacy of subtraction gadolinium-enhanced MRI in visualizing glomus tumors.
  • To assess the technique's utility in differentiating tumor types and guiding surgical decisions.

Main Methods:

  • Thirteen patients with 14 glomus tumors underwent T1-weighted MRI before and after gadolinium-DTPA contrast administration.
  • Subtraction imaging was employed to remove background signals, emphasizing vascularity.
  • Patients remained in the scanner during contrast injection to minimize motion artifacts.

Main Results:

  • Subtraction MRI effectively highlighted tumor vascularity by removing signals from fat and normal tissues.
  • The technique optimally demonstrated the extent of skull base glomus tumors.
  • Subtraction imaging aided in differentiating glomus tympanicum from glomus jugulare lesions.

Conclusions:

  • Subtraction gadolinium-enhanced MRI is a valuable tool for diagnosing and characterizing glomus tumors.
  • This technique improves surgical planning and is essential for post-operative surveillance of residual or recurrent tumors.